Top Markets
Coin of the day
Creso Pharma Limited Creso Pharma Limited

Creso Pharma Limited

CPH
Rangering i aksjer #30564
Creso Pharma Ltd. specializes in the development, registration, and... Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.
Aksjekurs
$0.00634756
Sist synkronisert: 2023-06-09
Markedsverdi
$16.30M
Endring (1 dag)
5.01%
Endring (1 år)
0.00%
Land
AU
Handel Creso Pharma Limited (CPH)

Kategori

Inntekter for Creso Pharma Limited (CPH)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Creso Pharma Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Creso Pharma Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter